For condition: Atopic Dermatitis
Atopic Dermatitis Study (34 Weeks)
Study Summary
Who Can Participate?
Adults aged between 18 and 70 with AD may participate.
Inclusion Criteria
- have chronic AD that has been present for ≥ 6 months
- have ≥ 10% body surface area (BSA) of AD involvement
- have a history of inadequate response to treatment for AD with topical medications; or determination that topical treatments are otherwise medically inadvisable
Participant Information
- Participate and receive study treatment at no cost
- Regular visits with study doctors who specialise in treating atopic dermatitis (18 visits)
- Will receive an investigative subcutaneous treatment (study drug) or a placebo
- Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
34 weeks
For more information about this trial, please visit ClinicalTrials.gov
